Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

298263

Sigma-Aldrich

Yttrium(III) chloride

beads, anhydrous, −10 mesh, 99.9%

Synonym(s):

Yttrium trichloride

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
YCl3
CAS Number:
10361-92-9
Molecular Weight:
195.26
EC Number:
233-801-0
MDL number:
MFCD00011470
UNSPSC Code:
12352302

grade

anhydrous

Assay

99.9%

form

beads

impurities

<100 ppm

particle size

−10 mesh

mp

721 °C (lit.)

density

2.67 g/mL at 25 °C (lit.)

SMILES string

Cl[Y](Cl)Cl

InChI

1S/3ClH.Y/h3*1H;/q;;;+3/p-3

InChI key

PCMOZDDGXKIOLL-UHFFFAOYSA-K

Looking for similar products? Visit Product Comparison Guide

Features and Benefits

Will react with potassium alkoxotitanates to form precursors to novel titanium-containing ceramics

Packaging

Packaged under argon in ampules

Signal Word

Danger

Hazard Statements

H317,H318,H410

Hazard Classifications

Aquatic Acute 1 - Aquatic Chronic 1 - Eye Dam. 1 - Skin Sens. 1B

Storage Class Code

13 - Non Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
06203KZ
05730DG
04604CQ
00709TY

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Acceleration of the substitution of silanes with Grignard reagents by using either LiCl or YCl3/MeLi.
Naoki Hirone et al.
Angewandte Chemie (International ed. in English), 49(42), 7762-7764 (2010-09-08)
S Hirano et al.
Toxicology and applied pharmacology, 121(2), 224-232 (1993-08-01)
Although radioactive yttrium (Y) has been used for medical treatment, little attention has been directed toward the toxicity of Y. We report time-course and dose-related changes in tissue distribution, subcellular localization, clearance, and acute toxicity of iv-injected yttrium chloride (YCl3)
F Zhang et al.
Physical review letters, 101(14), 148101-148101 (2008-10-15)
Negatively charged globular proteins in solution undergo a condensation upon adding trivalent counterions between two critical concentrations C and C, C <C. This reentrant condensation behavior above C is caused by short-ranged electrostatic interactions between multivalent cations and acidic residues
K Marubashi et al.
Toxicology letters, 99(1), 43-51 (1998-11-04)
We investigated pulmonary clearance of yttrium (Y) and acute lung injury following intratracheal instillation (i.t.) of yttrium chloride (YCl3) in saline- or YCl3-pretreated rats (30 days before the second challenge). About 67% of the initial dose of Y remained in
K Schomäcker et al.
Nuklearmedizin. Nuclear medicine, 36(2), 47-51 (1997-03-01)
Possibilities to exercise an influence on the biodistribution of a tumor-affine 153Sm-preparation, samarium-153-nitrilotriacetate (NTA), were tested. Animals experiments on tumor-bearing mice after additional application of EDTMP (ethylenediamine tetramethylene phosphonate) for the reduction of extratumorale liver-radioactivity and yttrium chloride for the
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service